サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1531001

タミフル（リン酸オセルタミビル）市場：世界の産業分析、規模、シェア、成長、動向、2024年～2034年予測

Tamiflu (Oseltamivir Phosphate) Market (Drug Type: Branded, and Generic; Dosage: Capsule, and Suspension; and Indication: Influenza A, Influenza B, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 187 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
タミフル（リン酸オセルタミビル）市場：世界の産業分析、規模、シェア、成長、動向、2024年～2034年予測
出版日: 2024年06月05日
発行: Transparency Market Research
ページ情報: 英文 187 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

タミフル（リン酸オセルタミビル）市場- 調査範囲

TMRの調査レポート「タミフル（リン酸オセルタミビル）の世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界のタミフル（リン酸オセルタミビル）市場の収益と予測を提供しています。また、2024年から2034年までの世界のタミフル（リン酸オセルタミビル）市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、タミフル（リン酸オセルタミビル）市場を推察しました。

市場スナップショット
2023年の市場規模 19億米ドル
2034年の市場規模 27億米ドル
CAGR 3.3%

当レポートでは、世界のタミフル（リン酸オセルタミビル）市場の競合情勢について調査しています。世界のタミフル（リン酸オセルタミビル）市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界のタミフル（リン酸オセルタミビル）市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020年～2034年

第5章 主要洞察

  • インフルエンザの世界的流行
  • ポーターのファイブフォース分析
  • 主要な業界イベント
  • 規制シナリオ

第6章 世界の市場分析と予測：薬剤タイプ別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測薬剤タイプ別、2020年～2034年
    • ブランド
    • ジェネリック
  • 医薬品の種類別の市場の魅力

第7章 世界の市場分析と予測：用量別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測投与量別、2020年～2034年
    • カプセル
    • サスペンション
  • 投与量による市場の魅力

第8章 世界の市場分析と予測：適応症別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測適応症別、2020年～2034年
    • インフルエンザA
    • インフルエンザB
    • その他
  • 適応症別の市場の魅力

第9章 世界の市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：流通チャネル別、2020年～2034年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他
  • 流通チャネル別の市場の魅力

第10章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第11章 北米の市場分析と予測

  • 米国
  • カナダ

第12章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第13章 アジア太平洋の市場分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリアとニュージーランド
  • その他アジア太平洋

第14章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第15章 中東・アフリカの市場分析と予測

  • GCC
  • 南アフリカ
  • その他中東・アフリカ

第16章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 市場シェア分析企業別（2022年）
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • NATCO Pharma Limited
    • Teva Pharmaceutical Industries Ltd
    • LUPIN Limited
    • Amneal pharmaceuticals LLC
    • Zydus Cadila
    • Sun Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • Mylan N.V.
    • Hetero Group
図表

List of Tables

  • Table 01: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 02: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 03: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 04: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 05: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 08: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 09: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 10: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 11: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 13: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 14: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 15: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 18: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 19: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 20: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 23: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 24: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 25: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 26: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 28: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 29: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 30: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Tamiflu (Oseltamivir Phosphate) Market Size, by Product, 2023
  • Figure 02: Tamiflu (Oseltamivir Phosphate) Market share (%), by Product, 2023
  • Figure 03: Tamiflu (Oseltamivir Phosphate) Market Size, by Dosage Form, 2023
  • Figure 04: Tamiflu (Oseltamivir Phosphate) Market Share (%), by Dosage Form, 2023
  • Figure 05: Tamiflu (Oseltamivir Phosphate) Market Size, by Application, 2023
  • Figure 06: Tamiflu (Oseltamivir Phosphate) Market share (%), by Application, 2023
  • Figure 07: Tamiflu (Oseltamivir Phosphate) Market Size, by Distribution Channel, 2023
  • Figure 08: Tamiflu (Oseltamivir Phosphate) Market share (%), by Distribution Channel, 2023
  • Figure 09: Global Tamiflu (Oseltamivir Phosphate) Market, By Region (2023 and 2034)
  • Figure 10: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 11: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 12: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023
  • Figure 13: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2034
  • Figure 14: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 15: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Branded, 2020-2034
  • Figure 16: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Branded, 2023 and 2034
  • Figure 17: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Generic, 2020-2034
  • Figure 18: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Generic, 2023 and 2034
  • Figure 19: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Others , 2020-2034
  • Figure 20: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 21: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 22: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023
  • Figure 23: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2034
  • Figure 24: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 25: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Capsule, 2020-2034
  • Figure 26: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Capsule, 2023 and 2034
  • Figure 27: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Suspension, 2020-2034
  • Figure 28: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Suspension, 2023 and 2034
  • Figure 29: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 30: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Application, 2023
  • Figure 31: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Application, 2034
  • Figure 32: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 33: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Influenza A, 2020-2034
  • Figure 34: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Influenza A, 2023 and 2034
  • Figure 35: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Influenza B, 2020-2034
  • Figure 36: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Influenza B, 2023 and 2034
  • Figure 37: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Others, 2020-2034
  • Figure 38: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Others, 2020-2034
  • Figure 39: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Others, 2023 and 2034
  • Figure 40: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 41: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023
  • Figure 42: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2034
  • Figure 43: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 44: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Hospital Pharmacies, 2020-2034
  • Figure 45: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Hospital Pharmacies, 2023 and 2034
  • Figure 46: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Retail Pharmacies, 2020-2034
  • Figure 47: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Retail Pharmacies, 2023 and 2034
  • Figure 48: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Others, 2020-2034
  • Figure 49: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 50: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 51: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 52: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 53: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 54: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country, 2023-2034
  • Figure 55: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 56: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 57: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 58: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 59: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 60: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 61: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 62: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 63: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 64: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 65: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 66: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 67: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 68: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 69: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 70: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 71: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 72: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 73: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 74: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 75: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 76: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 77: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 78: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 79: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 80: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 81: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 82: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 83: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 84: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 85: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 86: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 87: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 88: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 89: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 90: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 91: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 92: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 93: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 94: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 95: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 96: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 97: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 98: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 99: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 100: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 101: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 102: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 103: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 104: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 105: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 106: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
目次
Product Code: TMRGL70965

Tamiflu (Oseltamivir Phosphate) Market - Scope of Report

TMR's report on the global tamiflu (oseltamivir phosphate) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global tamiflu (oseltamivir phosphate) market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global tamiflu (oseltamivir phosphate) market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the tamiflu (oseltamivir phosphate) market.

Market Snapshot
Market Value in 2023US$ 1.9 Bn
Market Value in 2034US$ 2.7 Bn
CAGR3.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global tamiflu (oseltamivir phosphate) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global tamiflu (oseltamivir phosphate) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global tamiflu (oseltamivir phosphate) market.

The report delves into the competitive landscape of the global tamiflu (oseltamivir phosphate) market. Key players operating in the global tamiflu (oseltamivir phosphate) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global tamiflu (oseltamivir phosphate) market profiled in this report.

Key Questions Answered in Global tamiflu (oseltamivir phosphate) Market Report:

  • What is the sales/revenue generated by tamiflu (oseltamivir phosphate) across all regions during the forecast period?
  • What are the opportunities in the global tamiflu (oseltamivir phosphate) market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Tamiflu (Oseltamivir Phosphate) Market - Research Objectives and Research Approach

The comprehensive report on the global tamiflu (oseltamivir phosphate) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global tamiflu (oseltamivir phosphate) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global tamiflu (oseltamivir phosphate) market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Tamiflu (Oseltamivir Phosphate) Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Drug Type Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Influenza Flu Prevalence Globally
  • 5.2. Porter's Five Forces Analysis
  • 5.3. Key Industry Events
  • 5.4. Regulatory Scenario

6. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Drug Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Type, 2020-2034
    • 6.3.1. Branded
    • 6.3.2. Generic
  • 6.4. Market Attractiveness By Drug Type

7. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Dosage

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Dosage, 2020-2034
    • 7.3.1. Capsule
    • 7.3.2. Suspension
  • 7.4. Market Attractiveness By Dosage

8. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Indication, 2020-2034
    • 8.3.1. Influenza A
    • 8.3.2. Influenza B
    • 8.3.3. Others
  • 8.4. Market Attractiveness By Indication

9. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Distribution Channel, 2020-2034
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
    • 9.3.4. Others
  • 9.4. Market Attractiveness By Distribution Channel

10. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Drug Type, 2020-2034
    • 11.2.1. Branded
    • 11.2.2. Generic
  • 11.3. Market Value Forecast By Dosage, 2020-2034
    • 11.3.1. Capsule
    • 11.3.2. Suspension
  • 11.4. Market Value Forecast By Indication, 2020-2034
    • 11.4.1. Influenza A
    • 11.4.2. Influenza B
    • 11.4.3. Others
  • 11.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
    • 11.5.4. Others
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Drug Type
    • 11.7.2. By Dosage
    • 11.7.3. By Indication
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Type, 2020-2034
    • 12.2.1. Branded
    • 12.2.2. Generic
  • 12.3. Market Value Forecast By Dosage, 2020-2034
    • 12.3.1. Capsule
    • 12.3.2. Suspension
  • 12.4. Market Value Forecast By Indication, 2020-2034
    • 12.4.1. Influenza A
    • 12.4.2. Influenza B
    • 12.4.3. Others
  • 12.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
    • 12.5.4. Others
  • 12.6. Market Value Forecast By Country, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Drug Type
    • 12.7.2. By Dosage
    • 12.7.3. By Indication
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country

13. Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Type, 2020-2034
    • 13.2.1. Branded
    • 13.2.2. Generic
  • 13.3. Market Value Forecast By Dosage, 2020-2034
    • 13.3.1. Capsule
    • 13.3.2. Suspension
  • 13.4. Market Value Forecast By Indication, 2020-2034
    • 13.4.1. Influenza A
    • 13.4.2. Influenza B
    • 13.4.3. Others
  • 13.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
    • 13.5.4. Others
  • 13.6. Market Value Forecast By Country, 2020-2034
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Drug Type
    • 13.7.2. By Dosage
    • 13.7.3. By Indication
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country

14. Latin America Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Type, 2020-2034
    • 14.2.1. Branded
    • 14.2.2. Generic
  • 14.3. Market Value Forecast By Dosage, 2020-2034
    • 14.3.1. Capsule
    • 14.3.2. Suspension
  • 14.4. Market Value Forecast By Indication, 2020-2034
    • 14.4.1. Influenza A
    • 14.4.2. Influenza B
    • 14.4.3. Others
  • 14.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
    • 14.5.4. Others
  • 14.6. Market Value Forecast By Country, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Drug Type
    • 14.7.2. By Dosage
    • 14.7.3. By Indication
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country

15. Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Drug Type, 2020-2034
    • 15.2.1. Branded
    • 15.2.2. Generic
  • 15.3. Market Value Forecast By Dosage, 2020-2034
    • 15.3.1. Capsule
    • 15.3.2. Suspension
  • 15.4. Market Value Forecast By Indication, 2020-2034
    • 15.4.1. Influenza A
    • 15.4.2. Influenza B
    • 15.4.3. Others
  • 15.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
    • 15.5.4. Others
  • 15.6. Market Value Forecast By Country, 2020-2034
    • 15.6.1. GCC
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Drug Type
    • 15.7.2. By Dosage
    • 15.7.3. By Indication
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. F. Hoffmann-La Roche Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. NATCO Pharma Limited
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Teva Pharmaceutical Industries Ltd
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. LUPIN Limited
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Amneal pharmaceuticals LLC
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Zydus Cadila
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Sun Pharmaceutical Industries Ltd.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Alembic Pharmaceuticals Limited
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Mylan N.V.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Hetero Group
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview